Nebulized Colistin And Continuous Cyclic Azithromycin In Severe COPD Patients With Chronic Bronchial Infection Due To Pseudomonas aeruginosa: A Retrospective Cohort Study.
Concepción MontónElena PrinaXavier PomaresJose R CugatAntonio CasabellaJoan Carles OlivaMiguel GallegoEduard MonsóPublished in: International journal of chronic obstructive pulmonary disease (2019)
In patients with severe COPD and chronic bronchial infection due to P. aeruginosa, combination therapy with nebulized colistin and continuous cyclic azithromycin significantly reduced the number of ECOPD, with a marked decrease in P. aeruginosa sputum isolates.
Keyphrases
- pseudomonas aeruginosa
- combination therapy
- cystic fibrosis
- acinetobacter baumannii
- lung function
- chronic obstructive pulmonary disease
- escherichia coli
- biofilm formation
- multidrug resistant
- klebsiella pneumoniae
- drug resistant
- early onset
- gram negative
- mycobacterium tuberculosis
- pulmonary tuberculosis
- staphylococcus aureus
- air pollution